IFNAR1 and Zika virus infectious disease: This is consistent with reports that polyclonal anti-DENV antibody responses are capable of enhancing ZIKV disease within STAT2-/- mice (54, 87) as well as that anti-ZIKV immune plasma can enhance ZIKV infection in ifnar1 -/- mice (68).